osimertinib
astrazeneca
['mature data', 'osimertinib']
 adjuvant osimertinib making front page news we have been using this drug in the uk for 1 year+ as part of the cancer drugs fund based on immature data - the right decision and we have many patients already benefiting from this treatment. #asco2023 
Thoracic Medical Oncologist @BartsHospital, PhD in genomic medicine @Imperialcollege, Representative @ACPUK & @BTOGorg, @FMLM_UK clinical Fellow ‘18